These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 11504813

  • 1. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
    Truong JG, Newman AH, Hanson GR, Fleckenstein AE.
    Eur J Pharmacol; 2004 Nov 03; 504(1-2):27-32. PubMed ID: 15507217
    [Abstract] [Full Text] [Related]

  • 3. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK.
    J Pharmacol Exp Ther; 2000 May 03; 293(2):329-35. PubMed ID: 10772999
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Mar 03; 296(3):762-7. PubMed ID: 11181904
    [Abstract] [Full Text] [Related]

  • 5. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.
    Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE.
    J Neurosci; 2002 Oct 01; 22(19):8705-10. PubMed ID: 12351745
    [Abstract] [Full Text] [Related]

  • 6. Bupropion increases striatal vesicular monoamine transport.
    Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE.
    Neuropharmacology; 2005 Nov 01; 49(6):820-30. PubMed ID: 16005476
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA, Zhang XY, Kehoe P.
    J Pharmacol Exp Ther; 2005 Aug 01; 314(2):661-7. PubMed ID: 15845857
    [Abstract] [Full Text] [Related]

  • 8. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
    Schwendt M, Gold SJ, McGinty JF.
    J Neurochem; 2006 Mar 01; 96(6):1606-15. PubMed ID: 16539683
    [Abstract] [Full Text] [Related]

  • 9. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY, Martin-Iverson MT.
    Synapse; 1993 Jan 01; 13(1):20-9. PubMed ID: 8093985
    [Abstract] [Full Text] [Related]

  • 10. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.
    Truong JG, Hanson GR, Fleckenstein AE.
    Eur J Pharmacol; 2004 May 25; 492(2-3):143-7. PubMed ID: 15178358
    [Abstract] [Full Text] [Related]

  • 11. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME, Narang N, Wamsley JK.
    Synapse; 1993 Aug 25; 14(4):314-23. PubMed ID: 8161369
    [Abstract] [Full Text] [Related]

  • 12. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR, Sherman PS, Kuszpit K.
    Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
    Berglind WJ, Case JM, Parker MP, Fuchs RA, See RE.
    Neuroscience; 2006 Mar 01; 137(2):699-706. PubMed ID: 16289883
    [Abstract] [Full Text] [Related]

  • 14. Enhanced binding of dopamine D1 receptors in caudate-putamen subregions in High-Yawning Sprague-Dawley rats.
    Díaz-Romero M, Arias-Montaño JA, Eguibar JR, Flores G.
    Synapse; 2005 May 01; 56(2):69-73. PubMed ID: 15714477
    [Abstract] [Full Text] [Related]

  • 15. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
    Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2007 Nov 01; 323(2):738-45. PubMed ID: 17693585
    [Abstract] [Full Text] [Related]

  • 16. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
    Kiyatkin EA, Brown PL.
    Eur J Neurosci; 2005 Aug 01; 22(4):930-8. PubMed ID: 16115216
    [Abstract] [Full Text] [Related]

  • 17. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):129-40. PubMed ID: 11408534
    [Abstract] [Full Text] [Related]

  • 19. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L, Crooks PA, Dwoskin LP.
    J Neurochem; 1998 Jul 15; 71(1):258-65. PubMed ID: 9648873
    [Abstract] [Full Text] [Related]

  • 20. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2002 Mar 15; 300(3):1093-100. PubMed ID: 11861820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.